Equities

Stenocare A/S

Stenocare A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)1.22
  • Today's Change-0.07 / -5.43%
  • Shares traded73.03k
  • 1 Year change-63.58%
  • Beta0.9705
Data delayed at least 15 minutes, as of Nov 06 2024 16:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

  • Revenue in DKK (TTM)3.13m
  • Net income in DKK-16.81m
  • Incorporated2017
  • Employees9.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cyxone AB0.00-14.13m8.01m3.00--0.2684-----0.1388-0.13880.000.12480.00----0.00-59.57-63.71-66.38-69.40------------0.0157------45.87---13.31--
XP Chemistries AB250.91k-4.74m11.41m2.00--0.5219--45.46-0.2059-0.20590.00660.23570.01593.013.45196,770.00-29.91---31.74---1,218.83---1,887.54--3.76--0.00---37.14---1.55------
Lipigon Pharmaceuticals AB5.95m-12.91m15.32m----0.9519--2.58-0.3541-0.35410.10120.17020.2851--0.7439---61.91-314.67-76.67-426.49-----217.15-488.14----0.00----444.4467.83------
Ziccum AB3.54m-14.78m24.11m10.00--4.46--6.81-1.63-1.630.39030.53120.2749--3.31694,500.00-114.67-68.51-163.12-76.47-----417.19-2,598.03----0.0654----75.2025.62---13.45--
StenoCare A/S3.13m-16.81m26.07m9.00--1.27--8.34-1.04-1.040.18681.010.0948--2.07---50.98-28.16-68.69-35.47-----537.63-371.060.6143-6.070.2763---16.30---7.77------
QUIA PHARMA AB (publ)1.50m-8.84m26.60m8.00--1.20--17.68-2.02-2.020.01190.02330.0703--21.36---41.30-95.67-50.35-207.86160.51262.59-587.29-5,002.50---46.790.00------17.75--47.06--
Odi Pharma AB (publ)14.31m226.96k30.66m--135.1021.69134.002.140.02340.02341.470.14572.1954.425.47--3.48-35.0814.86-44.272.07--1.59-99.251.221.81----15,995.75--105.16------
Arctic Bioscience AS19.57m-30.13m32.87m20.00--0.2245--1.68-1.91-1.911.249.270.10570.6742.251,570,792.00-16.27---18.44--29.20---153.95--1.21--0.0075---1.52---33.77------
ExpreS2ion Biotech Holding AB5.16m-28.93m36.16m18.00--0.629--7.00-29.54-29.545.4742.930.0772--6.46311,461.50-43.23-63.54-56.21-75.88-123.56-1.94-560.27-524.31----0.0065--43.07-0.156122.94--19.90--
Elicera Therapeutics AB7.70m-13.25m44.19m2.00--2.68--5.74-0.9137-0.91370.50590.73770.3224--12.856,035,610.00-55.51-40.06-79.82-49.74-----172.21-415.41----0.00--777.23--15.64------
Oncozenge AB0.00-7.51m68.78m----7.59-----1.01-1.010.001.210.00-------55.08---59.44-------------2,944.500.00------65.91------
Lipidor AB55.47k-8.63m72.60m----6.77--1,308.93-0.1505-0.15050.00090.02070.005--0.1843---77.12-59.41-178.11-75.10-----15,550.58-643.36----0.00--73.33-20.3372.24------
Data as of Nov 06 2024. Currency figures normalised to Stenocare A/S's reporting currency: Danish Krone DKK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.